A new preprint study shatters the idea that pediatric long COVID is just a mild or different version of the adult form.
It shows that children share the same core immune patterns - and, strikingly, some resemble those seen in chronic infections like HIV.🧵
The paper message is clear - pediatric LC is biologically defined immune dysfunction.
Children display
shifts in monocytes (↑ non-classical, ↓ CCR6),
T cell changes (↑ Tregs, ↓ central memory CD4, exhausted CD8),
exhausted B cells.
At the root lies a failure of antigen-presenting cells (monocytes & dendritic cells).
Normally, they carry viral information to T and B cells. But in LC, they express less CCR6/CCR7 - they can’t migrate properly to lymph nodes or activate adaptive immunity.
“Suppressed expression of CCR6 and CCR7… could impair antigen presentation and adaptive immunity.”
The consequence?
B cells don’t mount a strong antibody response.
Children with LC had significantly lower anti-RBD IgG and IgA titers, and their antibodies neutralized the virus less effectively.
The virus can persist in tissues, like the gut.
Meanwhile, T and NK cells become hyperactivated.
On the surface this looks like a strong immune defense. But in reality, it’s a dead end.
These cells show exhaustion markers (PD1, CD57, CD38, HLA-DR↑).
“Elevated expression of activation and exhaustion markers…”
A vicious cycle?
Persistence - activation - exhaustion - persistence again.
And here’s the striking part - the authors explicitly point to parallels with HIV.
“Elevated CXCR3 expression on CD8 TCM has also been reported in people living with HIV-1, suggesting a shared trait of chronic viral infections.”
The same is true for B cells.
Cluster 15 B cells show an exhausted-like phenotype -
“…commonly observed in chronic viral infections such as HIV-1.”
SARS-CoV-2 can imprint the immune system in children in ways that mimic chronic viral disease.
In pediatric LC, CD8 stem-cell like memory T cells (TSCM) decreased, while central memory T cells (TCM) increased.
And within TCM, there was a shift toward CXCR3+/CCR6+ cells - a phenotype of chronic stimulation.
The clinical point is sobering.
Weak antibodies + exhausted T/NK cells = a recipe for viral persistence.
When APCs don’t work (CCR6/CCR7↓), B cells never make high-quality antibodies.
The virus hides, the immune system pushes harder, and burns itself out.
The result?
A state of chronic immune imbalance.
Maybe less dramatic than HIV, but uncannily similar.
Pediatric LC emerges as a model of chronic viral immunopathology - not a psychological aftermath, but a biological condition with measurable immune signatures.
And perhaps we won’t need to argue about these parallels for long.
The authors themselves are already drawing them - between pediatric LC, adults with LC, and chronic infections like HIV.
Pujol et al., 2025. Pediatric Long COVID Is Characterized by Myeloid CCR6 Suppression and Immune Dysregulation. biorxiv.org/content/10.110…
Dobře si to přečtěte @szupraha @ZdravkoOnline @msmtcr @Hygiena_cz. LC je dnes nejčastější chronické onemocnění u dětí - překonává astma.
Tohle jsou následky vaší nečinnosti.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
A new narrative review in Communications Medicine sums up where the field stands on long COVID.
Not as one single, uniform diagnosis, but as a complex, multisystem condition after SARS2 infection🧵
Its value is in the synthesis. It brings together immunology, neurology, vascular biology, metabolism, and clinical medicine into one framework.
The review covers prevalence, pathophysiology, biomarkers, treatment strategies, and future research directions. It is a broad interpretation of the current literature.
A heart attack after COVID may not look like the classic heart attack we usually imagine.
A new core-lab study of patients with NSTEMI + COVID-19 suggests something more diffuse. Not just one blocked artery, but a blood-clotting and vessel inflammation problem🧵
First, two key terms.
STEMI is the type of heart attack where the ECG shows ST-segment elevation. It often means a major coronary artery is suddenly blocked.
NSTEMI is a heart attack without that classic ST elevation. It can be less obvious on ECG, but it is not minor.
So STEMI is often like a main pipe suddenly being blocked.
NSTEMI can be more complex. Partial blockage, smaller clots, multiple narrowed vessels, poor microvascular flow, or the heart being stressed by illness.
But COVID can add another layer.
For 2025, the societal cost of Long COVID and ME/CFS in Germany is estimated at €64.4 billion - about 1.44% of GDP.
For Czechia, this would roughly translate to around CZK 120 billion per year if we apply the same share of GDP - 1.44% of the Czech economy.
A simple population-based conversion would produce a higher number (200 billion), but that is an overestimate.
This should matter to you, @strakovka.
Because this is what poor public health policy costs. Ignoring prevention, ventilation, surveillance, post-COVID care, and the long-term damage caused by repeated infections.
A new systematic review looked at what happens to the heart after COVID - not during the acute infection, but months later.
The key point:
A normal ejection fraction does not always mean the heart is completely unaffected.🧵
In people assessed more than 12 weeks after PCR confirmed COVID - especially those with persistent cardiopulmonary symptoms - there is evidence of subtle, and sometimes persistent, cardiac involvement.
This may show up as
higher BNP/NT-proBNP
reduced LV-GLS
abnormalities on cardiac MRI
while LVEF often remains normal
Exertion and PEM.
A new paper studied people with long COVID using a 2-day (!) submaximal CPET protocol, combined with NIRS measurement on the calf muscle.
The authors looked at what happens to breathing, performance, and muscle oxygenation during repeated exertion🧵
The key finding.
In the long COVID group, muscle tissue oxygen saturation (TSI%) initially increased during exercise, but it did not stay elevated for as long as it did in controls. (Thomas 2026)
On day 2, this pattern was even worse. In long COVID, TSI% stayed above resting levels for a shorter period, while controls maintained elevated muscle oxygenation more effectively during exercise.
COVID-19 creates a state of immune dysregulation where the body may lose control over things it normally keeps suppressed - latent viruses, especially herpesviruses, and possibly even dormant cancer cells.
A new study on EBV and CD8 T cells fits into this bigger picture.🧵
The point is not simply that EBV can reactivate during COVID. We already have quite a lot of evidence for that.
In hospitalized patients with acute COVID, EBV reactivation was very common - around 68-73% - and it was seen not only in critical cases, but also in moderate disease.
The authors looked at EBV, CMV, HHV-6A and HHV-6B.
EBV dominated.
CMV and HHV-6B were detected only at low frequencies.
HHV-6A was not detected at all.
So this does not look like just random viral noise. EBV stands out.